A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

PHASE3CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

February 23, 2009

Primary Completion Date

June 27, 2012

Study Completion Date

June 27, 2012

Conditions
Pulmonary Hypertension
Interventions
DRUG

Riociguat (Adempas, BAY63-2521)

BAY63-2521: 1 mg tid - 2,5 mg tid orally for 16 weeks.

DRUG

Placebo

Matching Placebo tid orally for 16 weeks

Trial Locations (89)

100

Taipei

1070

Bruxelles - Brussel

1090

Vienna

3000

Leuven

3181

Prahran

3400

Corrientes

6020

Innsbruck

8091

Zurich

8200

Aarhus N

12808

Vseobecna fakultni nemocnice, Prague

14033

Caen

14080

Mexico City

17475

Greifswald

20251

Hamburg

21205

Baltimore

27100

Pavia

28041

Madrid

30625

Hanover

33136

Miami

33604

Pessac

34093

Istanbul

35040

Izmir

35392

Giessen

38000

Querétaro

43221

Columbus

44195

Cleveland

50924

Cologne

52242

Iowa City

59037

Lille

64020

Monterrey

64460

Monterrey

66421

Homburg

69120

Heidelberg

69126

Heidelberg

75390

Dallas

76031

Rouen

81377

München

92093

La Jolla

92141

Hopital Antoine Beclere, Clamart

95817

Sacramento

97074

Würzburg

100020

Beijing

100037

Beijing

100038

Beijing

197341

Saint Petersburg

200433

Shanghai

266003

Qingdao

630055

Novosibirsk

02118

Boston

90020 090

Porto Alegre

04020-050

São Paulo

21941-913

Rio de Janeiro

T1Y 6J4

Calgary

N6A 4G5

London

K1Y 4W7

Ottawa

M5G 2N2

Toronto

H3T 1E2

Montreal

F-29609

Brest

06200

Nice

F-54500

Vandœuvre-lès-Nancy

01307

Dresden

04103

Leipzig

467-8602

Nagoya

489-8642

Seto

802-8555

Kitakyushu

923-8560

Komatsu

251-0041

Fujisawa

216-8511

Kawasaki

980-8574

Sendai

392-8510

Suwa

565-8565

Suita

113-8655

Bunkyo-ku

181-8611

Mitaka

160-8582

Shinjuku-ku

162-8655

Shinjuku-ku

260-8677

Chiba

812-8582

Fukuoka

1081 HV

Amsterdam

31-202

Krakow

05-400

Otwock

3000-075

Coimbra

833 48

Bratislava

06351

Seoul

138-736

Seoul

08036

Barcelona

Unknown

Ankara

CB23 3RE

Cambridge

G81 4DY

Glasgow

W12 0HS

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY